home / stock / crmd / crmd news


CRMD News and Press, CorMedix Inc. From 03/12/24

Stock Information

Company Name: CorMedix Inc.
Stock Symbol: CRMD
Market: NYSE
Website: cormedix.com

Menu

CRMD CRMD Quote CRMD Short CRMD News CRMD Articles CRMD Message Board
Get CRMD Alerts

News, Short Squeeze, Breakout and More Instantly...

CRMD - Expected US Company Earnings on Tuesday, March 12th, 2024

Koninklijke KPN NV (KKPNF) is expected to report for Q4 2023 ECA Marcellus Trust I Unit (ECTM) is expected to report for Q4 2023 San Juan Basin Royalty Trust (SJT) is expected to report for Q4 2023 Avenir Wellness Solutions Inc (AVRW) is expected to report for Q4 2023 Carmell Corp...

CRMD - CorMedix Q4 2023 Earnings Preview

2024-03-11 12:08:19 ET More on CorMedix Seeking Alpha’s Quant Rating on CorMedix Historical earnings data for CorMedix Financial information for CorMedix Read the full article on Seeking Alpha For further details see: CorMedix Q4 2023 Earni...

CRMD - Earnings week ahead: Oracle, Adobe, Zim Integrated and more

2024-03-11 05:50:46 ET More on related stocks: Oracle Q3 Earnings Preview: Cloud Computing Business In Focus Blink Charging: EV Tailwinds Offer A Path To Profitability In 2025 Ulta Beauty: We Are Not Adding To Our Position Before The Earnings Release (Rating Downgrad...

CRMD - CorMedix Inc. to Report Fourth Quarter and Full Year 2023 Financial Results and Provide a Corporate Update on March 12, 2024

BERKELEY HEIGHTS, N.J., March 06, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced that it will re...

CRMD - CorMedix Inc. Announces Commercial and Reimbursement Updates

BERKELEY HEIGHTS, N.J., Jan. 30, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced updates related to its b...

CRMD - CorMedix Inc. Announces Commercial and Operational Updates

BERKELEY HEIGHTS, N.J., Jan. 08, 2024 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening diseases and conditions, today announced several commercial and o...

CRMD - FDA's new drug approvals for 2023 rise 51% from last year

2023-12-27 12:29:36 ET More on AbbVie, Johnson & Johnson, etc. Pfizer: Why I Am Buying The 5.92% Yield After The 2.4% Dividend Increase Eli Lilly: Consider Cutting Before The Southbound Train Leaves (Rating Downgrade) AbbVie Vs. GSK: Dual Dominance In Pharma ...

CRMD - SPWR, EVGO and ACHR are among after hour movers

2023-12-20 16:50:54 ET Gainers: Infrared Cameras Holdings ( MSAI ) +15% . EVgo  ( EVGO ) +6% . Micron Technology ( MU ) +5% . Ramaco Resources ( METC ) +4% . CorMedix ( CRMD ) +4% . Losers: Cogent Biosciences ( COG...

CRMD - CorMedix collaborates with The Leapfrog Group

2023-12-04 09:09:40 ET More on CorMedix CorMedix rallies on FDA nod for anti-infective agent DefenCath Seeking Alpha’s Quant Rating on CorMedix For further details see: CorMedix collaborates with The Leapfrog Group

CRMD - CorMedix Inc. Announces Partnership With The Leapfrog Group

– CorMedix to advocate for patient safety and infection prevention as part of Leapfrog’s Partners Advisory Committee BERKELEY HEIGHTS, N.J., Dec. 04, 2023 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercial...

Previous 10 Next 10